We are building Gemini — a next-gen in silico drug discovery and repurposing platform combining gen AI and quantum computing
We are building Gemini — a next-gen in silico drug discovery and repurposing platform combining gen AI and quantum computing
The Gemini platform integrates three core capabilities into one unified system:
We deliver exceptional results in everything we do, ensuring your satisfaction at every step.
Our experienced team brings skill and passion to every project, no matter the size.
Proven outcomes that speak for themselves and make a meaningful difference for your business.
Two integrated modules — generative AI and quantum computing — working in a closed feedback loop:
Generative AI
There are estimated to be about 10 ^ 60 candidate drug molecules. If a trillion molecules were tested every second since the beginning of the universe using virtual screening, this would hardly touch the surface of this vast molecular space. Generative AI can be trained to search the entire space of candidate drug molecules much more efficiently.
Quantum computing
Quantum molecular modelling delivers far more accurate predictions of pharmacological properties than classical methods — ensuring generated molecules behave as predicted. This leads to:
Personalized service tailored to your unique needs.
Experienced professionals dedicated to your success.
Proven results that speak for themselves.
